DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Miles DW, Chan A, Dirix LY et al.
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.
J Clin Oncol 2010;
28: 3239-3247
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.